Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand

被引:118
作者
Sukvirach, S
Smith, JS
Tunsakul, S
Muñoz, N
Kesararat, V
Opasatian, O
Chichareon, S
Kaenploy, V
Ashley, R
Meijer, CJLM
Snijders, PJF
Coursaget, P
Franceschi, S
Herrero, R
机构
[1] Int Agcy Res Canc, Unit Field & Intervent Studies, F-69372 Lyon 08, France
[2] Natl Canc Inst, Div Res, Bangkok, Thailand
[3] Prov Hlth Off, Lampang, Thailand
[4] Prince Songkla Univ, Hat Yai, Thailand
[5] Prov Hlth Off, Songkhla, Thailand
[6] INSERM, Mol Virol Lab, Tours, France
[7] Univ Washington, Seattle, WA 98195 USA
[8] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[9] Proyecto Epidemiol Guanacaste, San Jose, Costa Rica
[10] Lampang Hosp, Lampang, Thailand
关键词
D O I
10.1086/373901
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the prevalence and determinants of human papillomavirus (HPV) infection, the primary cause of cervical cancer, we studied 1741 women greater than or equal to15 years of age from Lampang and Songkla, Thailand. Exfoliated cervical cells were collected for Papanicolaou smear screening and DNA detection of 36 different HPV types. Serum immunoglobulin G antibodies against L1 virus-like particles (anti-VLPs) of HPV-16, -18, -31, -33, and -58 were evaluated using enzyme-linked immunosorbent assay. Overall, 110 women (6.3%) were HPV DNA positive; the most common types were HPV-16, -52, and -72. The age-standardized prevalence of HPV DNA was higher among the 1035 women from Lampang (9.1%; 95% confidence interval [CI], 7.1-11.1) than among the 706 women from Songkla (3.9%; 95% CI, 2.3%-5.6%). Anti-VLPs were found in 21.8% of all women and were more frequent among women from Lampang (29.2%) than among women from Songkla (10.9%). Major risk factors for cervical HPV DNA were age <35 years, HSV-2 seropositivity, and having a husband with extramarital sexual partners.
引用
收藏
页码:1246 / 1256
页数:11
相关论文
共 54 条
[1]  
Bhattarakosol Parvapan, 1996, Journal of the Medical Association of Thailand, V79, pS56
[2]   Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain [J].
Bosch, FX ;
Castellsague, X ;
Munoz, N ;
deSanjose, S ;
Ghaffari, AM ;
Gonzalez, LC ;
Gili, M ;
Izarzugaza, I ;
Viladiu, P ;
Navarro, C ;
Vergara, A ;
Ascunce, N ;
Guerrero, E ;
Shah, KV .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (15) :1060-1067
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]   Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women [J].
Burk, RD ;
Ho, GYF ;
Beardsley, L ;
Lempa, M ;
Peters, M ;
Bierman, R .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :679-689
[5]   Human papillomavirus genotypes in rural Mozambique [J].
Castellsagué, X ;
Menéndez, C ;
Loscertales, MP ;
Kornegay, JR ;
dos Santos, F ;
Gómez-Olivé, FX ;
Lloveras, B ;
Abarca, N ;
Vaz, N ;
Barreto, A ;
Bosch, FX ;
Alonso, P .
LANCET, 2001, 358 (9291) :1429-1430
[6]   Risk factors for cervical cancer in Thailand:: A case-control study [J].
Chichareon, S ;
Herrero, R ;
Muñoz, N ;
Bosch, FX ;
Jacobs, MV ;
Deacon, J ;
Santamaria, M ;
Chongsuvivatwong, V ;
Meijer, CJLM ;
Walboomers, JMM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (01) :50-57
[7]   Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[8]   Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer [J].
Combita, AL ;
Bravo, MM ;
Touzé, A ;
Orozco, O ;
Coursaget, P .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) :796-803
[9]   Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses [J].
Combita, AL ;
Touzé, A ;
Bousarghin, L ;
Christensen, ND ;
Coursaget, P .
JOURNAL OF VIROLOGY, 2002, 76 (13) :6480-6486
[10]   ANTIBODY TO HERPES-SIMPLEX VIRUS TYPE-2 AS SEROLOGICAL MARKER OF SEXUAL LIFE-STYLE IN POPULATIONS [J].
COWAN, FM ;
JOHNSON, AM ;
ASHLEY, R ;
COREY, L ;
MINDEL, A .
BRITISH MEDICAL JOURNAL, 1994, 309 (6965) :1325-1329